2022
DOI: 10.21037/qims-21-1043
|View full text |Cite
|
Sign up to set email alerts
|

Computed tomography-guided microwave ablation for non-small cell lung cancer patients on antithrombotic therapy: a retrospective cohort study

Abstract: Background: For non-small cell lung cancer (NSCLC) patients on antithrombotic therapy who are treated with microwave ablation (MWA), the transient interruption of antithrombotic agents may increase the risk of thromboembolism, and continuation of antithrombotic agents may increase the risk of intraprocedural hemorrhage. This retrospective cohort study aimed to explore the safety of MWA in patients with NSCLC on antithrombotic therapy.Methods: A total of 572 patients with NSCLC (antithrombotic therapy group: n=… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…The goals of CNB are to obtain genomic testing for previously diagnosed NSCLC or to achieve both pathological diagnosis and genomic testing for suspicious NSCLC. As described previously [ 21 ], an MTC-3 C MWA system (Vison Medicine, China) was used for ablation, with a microwave emission frequency of 2,450 ± 50 MHz and an adjustable power of 20–80 W. The MWA antennas (Vison) were 15–18 cm in effective length and 16–18 G in outside diameter, with a 15 mm active tip. Preprocedural CT was performed to conduct the ablation plan and to clarify the suitable position, puncture site location, optimal puncture trajectory, and the number of MWA antennas.…”
Section: Methodsmentioning
confidence: 99%
“…The goals of CNB are to obtain genomic testing for previously diagnosed NSCLC or to achieve both pathological diagnosis and genomic testing for suspicious NSCLC. As described previously [ 21 ], an MTC-3 C MWA system (Vison Medicine, China) was used for ablation, with a microwave emission frequency of 2,450 ± 50 MHz and an adjustable power of 20–80 W. The MWA antennas (Vison) were 15–18 cm in effective length and 16–18 G in outside diameter, with a 15 mm active tip. Preprocedural CT was performed to conduct the ablation plan and to clarify the suitable position, puncture site location, optimal puncture trajectory, and the number of MWA antennas.…”
Section: Methodsmentioning
confidence: 99%